stockrow
Tuesday 3 November 2026
Export MOH’s income statement to Excel — free account
Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024.
- Revenue
- −3.44%
- EPS
- −51.7%
- Free cash flow
- −20.3%
- Total debt
- +2.54%
Quarter to September 2026, against a year earlier
208.66
0.21
+0.10%
Follow MOH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
20.27 | 39.44 | 0.00 | 0.00 |
P/S ratio |
0.20 | 0.15 | 0.26 | 0.22 | |
P/FCF ratio |
0.00 | 27.03 | 43.12 | 40.68 | |
P/Operating CF |
(30.75) | 6.27 | (39.75) | (60.89) | |
P/B ratio |
2.25 | 1.66 | 2.80 | 2.33 | |
Price to Tangible BV |
4.89 | 3.41 | 5.59 | 4.65 | |
EV/Sales |
0.11 | 0.03 | 0.15 | 0.12 | |
EV/EBITDA |
5.00 | 2.44 | 18.20 | 15.25 | |
EV/Operating CF |
(9.13) | 4.22 | 18.49 | 15.34 | |
EV/FCF |
(7.68) | 6.00 | 24.91 | 21.34 | |
Quick Ratio |
1.60 | 1.55 | 1.61 | 1.61 | |
Current Ratio |
1.69 | 1.63 | 1.68 | 1.69 | |
Net Debt/EBITDA |
36.49 | (43.48) | (26.82) | (32.15) | |
Debt/Assets |
25.38% | 24.08% | 24.70% | 25.24% | |
Debt/Equity |
0.97 | 0.97 | 0.95 | 0.95 | |
Asset Turnover |
2.91 | 2.75 | 2.76 | 2.82 | |
Operating CF/Net income |
1.86 | 77.29 | (4.90) | (4.18) | |
Capex/Depreciation |
0.02 | (0.69) | (0.75) | (0.97) | |
Interest Coverage |
(3.12) | 1.54 | 2.69 | 2.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.99% | 7.22% | 6.66% | 6.41% | |
Intangible Assets out of Total Assets |
0.14 | 0.13 | 0.13 | 0.13 | |
Share Based Compensation of Revenue |
0.18% | 0.31% | 0.24% | 0.23% | |
Graham Net Nets |
0.10 | 0.15 | 0.09 | 0.11 | |
Graham Number |
121.83 | 78.08 | 0.00 | 0.00 | |
Earnings Yield |
4.93% | 2.54% | (0.08%) | (0.51%) | |
Free Cash Flow Yield |
(6.94%) | 3.70% | 2.32% | 2.46% | |
Revenue per Share |
215.44 | 212.10 | 212.80 | 216.45 | |
Operating CF per Share |
(5.64) | 21.26 | (5.75) | (3.11) | |
Capex per Share |
0.02 | (0.53) | (0.59) | (0.72) | |
Free Cash Flow per Share |
(5.62) | 20.73 | (6.34) | (3.83) | |
Cash per Share |
156.36 | 181.75 | 174.46 | 167.56 | |
Shareholders Equity per Share |
77.06 | 80.16 | 81.62 | 81.15 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
77.06 | 80.16 | 81.62 | 81.15 | |
Free Cash Flow |
(297.00) | 1,055.00 | (324.00) | (196.00) | |
Working Capital |
5,072.00 | 5,138.00 | 5,228.00 | 5,120.00 | |
Capital Expenditures |
1.00 | (27.00) | (30.00) | (37.00) | |
Net Current Asset Value |
949.00 | 1,015.00 | 1,096.00 | 1,017.00 | |
EV/EBIT |
6.25 | 3.50 | 33.25 | 29.53 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
11.73 | 15.74 | 57.57 | 56.29 | |
| Other line items | |||||
Average Receivables |
3,416.00 | 3,455.50 | 3,675.00 | 3,437.00 | |
Average Payables |
1,212.00 | 1,140.00 | 1,126.00 | 1,153.50 | |
Average Assets |
15,597.00 | 16,388.50 | 16,106.00 | 15,675.00 | |
Average Common Equity |
4,282.50 | 4,195.00 | 4,387.00 | 4,173.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026